U.S. FDA Considers Using Third-Party Inspectors to Enhance Global Reach
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is talking about adding an outsourced inspectorate to help it police the globally outsourced pharmaceutical manufacturing industry